Chronic Antiplatelet Agent use is Associated with Decreased 90-Day Morbidity and Mortality in Patients with Acute Pancreatitis

Authors

Do Han Kim MD, Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Donghyun Ko, Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA.Follow
Pedro Palacios Argueta MD, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Wilhelm S. Basegoda MD, University of South Alabama, Mobile, AL, USA
Jose A. Porres, Universidad Francisco Marroquin, Guatemala City, Guatemala.
Frank J. Lukens MD, Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA
Paul T. Kroner MD, Department of Gastroenterology, Riverside Health System, Newport News, VA, USA.

Document Type

Conference Proceeding

Abstract

The aim of this study is to explore the association between the use of antiplatelets and outcomes of patients with AP using a large multinational database.

Publication Date

5-2025

Recommended Citation

Kim, Do Han MD; Ko, Donghyun; Palacios Argueta, Pedro MD; Basegoda, Wilhelm S. MD; Porres, Jose A.; Lukens, Frank J. MD; and Kroner, Paul T. MD, "Chronic Antiplatelet Agent use is Associated with Decreased 90-Day Morbidity and Mortality in Patients with Acute Pancreatitis" (2025). Posters. 94.
https://scholar.bridgeporthospital.org/poster_presentations/94